A 45-year-old woman with obsessive-compulsive disorder

JAMA

Volumn 285, Issue 16, 2001, Pages 2121-2128

  Jenike, Michael A ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; LITHIUM CARBONATE; METHYLPHENIDATE; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE;

ADULT; ARTICLE; CASE REPORT; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; OBSESSION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0035946702     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.16.2121     Document Type: Article

References (55)

1. The epidemiology and clinical features of obsessive compulsive disorder
2. Posttraumatic obsessive-compulsive disorder: A three-factor model
3. Obsessive-impulsions consecutives a l'encephalite epidemique
4. Case study: Acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy
5. On defining Sydenham's chorea: Where do we draw the line?
6. Immune mechanisms in pediatric neuropsychiatric disorders: Tourettes syndrome, OCD, and PANDAS
7. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
8. Obsessive-compulsive neurosis following head injury: A report of four cases
9. Obsessive-compulsive disorder and head trauma: A rare association
10. Local cerebral glucose metabolic rates in obsessive-compulsive disorder
11. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 15-O labeled CO2 and positron emission tomography
12. Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder
13. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography
14. Brain MRI in obsessive-compulsive disorder
15. A compulsive movement disorder with cavitation of caudate nucleus
16. Focal striatal abnormalities in a patient with obsessive-compulsive disorder
17. Late-onset obsessive compulsive disorder: A case series
18. Nuclear magnetic resonance study of obsessive-compulsive disorder
19. Cerebral structural abnormalities in patients with obsessive-compulsive disorder: A quantitative morphometric magnetic resonance imaging study
20. Neurobiological models of obsessive compulsive disorder
21. Neural mechanisms of obsessive-compulsive disorder
22. Genetic aspects of obsessive-compulsive disorder
23. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature
24. Longterm follow-up of 85 patients with obsessive compulsive disorder
25. Obsessive-compulsive disorder: Efficacy of specific treatments as assessed by controlled trials
26. Open treatment of obsessive-compulsive disorder with venlafaxine: A series of ten cases
27. Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls
28. Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment
29. Medication withdrawal symptoms in obsessive compulsive disorder patients treated with paroxetine
30. The SSRI discontinuation syndrome
31. A primer on geriatric psychopharmacology
32. Augmentation strategies for treatment-resistant obsessive-compulsive disorder
33. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics
34. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
35. Is there a relationship between clozapine and obsessive-compulsive disorder? A retrospective chart review
36. Exacerbation of obsessive compulsive symptoms associated with clozapine
37. Development of obsessive compulsive symptoms during clozapine treatment
38. Risperidone, serotonergic mechanisms and obsessive compulsive symptoms in schizophrenia
39. Emergence of obsessive compulsive symptoms during treatment with clozapine
40. Obsessive-compulsive symptoms with neuroleptics
41. Discontinuation and long-term treatment of obsessive compulsive disorder
42. Cognitive-behavioral therapy for anxiety disorders: Why and how it works
43. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples
44. Understanding and treating obsessive-compulsive disorder
45. Home self-assessment and self-treatment of obsessive-compulsive disorder using a manual and a computer-conducted telephone interview: Replication of a UK-US study
46. Neurosurgical treatment of obsessive-compulsive disorder
47. Deep brain stimulation (DBS) therapy for Parkinson's disease
48. Effect and time course of deep brain stimulation of the globus pallidus and subthalamus on motor features of Parkinson's disease
49. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease
50. Concomitant obsessive-compulsive disorder and schizotypal personality disorder
51. Coexistent obsessive-compulsive disorder and schizotypal personality disorder: A poor prognostic indicator
52. Standardized assessment of personality disorders in obsessive-compulsive disorder